<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shen A</submitter><funding>NIGMS NIH HHS</funding><pagination>963-77</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3153235</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(5)</volume><pubmed_abstract>Protease domains within toxins typically act as the primary effector domain within target cells. By contrast, the primary function of the cysteine protease domain (CPD) in Multifunctional Autoprocessing RTX-like (MARTX) and Clostridium sp. glucosylating toxin families is to proteolytically cleave the toxin and release its cognate effector domains. The CPD becomes activated upon binding to the eukaryotic-specific small molecule, inositol hexakisphosphate (InsP(6)), which is found abundantly in the eukaryotic cytosol. This property allows the CPD to spatially and temporally regulate toxin activation, making it a prime candidate for developing anti-toxin therapeutics. In this review, we summarize recent findings related to defining the regulation of toxin function by the CPD and the development of inhibitors to prevent CPD-mediated activation of bacterial toxins.</pubmed_abstract><journal>Toxins</journal><pubmed_title>Autoproteolytic activation of bacterial toxins.</pubmed_title><pmcid>PMC3153235</pmcid><funding_grant_id>K99 GM092934-01</funding_grant_id><funding_grant_id>K99 GM092934</funding_grant_id><pubmed_authors>Shen A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Autoproteolytic activation of bacterial toxins.</name><description>Protease domains within toxins typically act as the primary effector domain within target cells. By contrast, the primary function of the cysteine protease domain (CPD) in Multifunctional Autoprocessing RTX-like (MARTX) and Clostridium sp. glucosylating toxin families is to proteolytically cleave the toxin and release its cognate effector domains. The CPD becomes activated upon binding to the eukaryotic-specific small molecule, inositol hexakisphosphate (InsP(6)), which is found abundantly in the eukaryotic cytosol. This property allows the CPD to spatially and temporally regulate toxin activation, making it a prime candidate for developing anti-toxin therapeutics. In this review, we summarize recent findings related to defining the regulation of toxin function by the CPD and the development of inhibitors to prevent CPD-mediated activation of bacterial toxins.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 May</publication><modification>2020-11-19T12:28:20Z</modification><creation>2019-03-27T03:07:51Z</creation></dates><accession>S-EPMC3153235</accession><cross_references><pubmed>22069620</pubmed><doi>10.3390/toxins2050963</doi></cross_references></HashMap>